Sign In  |  Register  |  About San Rafael  |  Contact Us

San Rafael, CA
September 01, 2020 1:37pm
7-Day Forecast | Traffic

  • Search Hotels in San Rafael

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

16.57 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
24 25 Next >
Putin on the brink
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott. 
Via Talk Markets
Red Ink
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph 
Via Talk Markets
A Receding tide
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient. 
Via Talk Markets
World Markets News For Thursday
Ericsson stock lost another 5.27% today in US markets. 
Via Talk Markets
Why Are Teva Pharmaceutical Shares Trading Higher Today?
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)  
Via Benzinga
The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical
Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled. 
Via Investor's Business Daily
Earnings Scheduled For February 9, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion. 
Via Benzinga
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept... 
Via FinancialNewsMedia
Exposures COVID-19
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
According to Coherent Market Insights, the global cannabis extract market is estimated to be valu... 
Via Benzinga
Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment
A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun O... 
Via Benzinga
Price To Earnings Ratio Insights For Teva Pharmaceutical
  
Via Benzinga
Teva, Texas Enter $225M Opioid Settlement Agreement
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a  
Via Benzinga
World Markets News For Monday
European markets were down over fear of Ukrainian battles. 
Via Talk Markets
Nuclear Winter
Mexico is raising interest rates to 6%, from 5.5%. 
Via Talk Markets
Inflation inflating
The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays. 
Via Talk Markets
Dampening Exuberance
The bond sell-off halted today but the Fed's plans mean this will resume. 
Via Talk Markets
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Teva Pharmaceutical: Q4 Earnings Insights
  Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
Markets News for Tuesday
Oil stocks are up on huge gains. 
Via Talk Markets
Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims
From Teva Pharmaceutical Industries Limited
Via Business Wire
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
Weakened Tech Stocks
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks. 
Via Talk Markets
World Markets News for Wednesday
Gold and the Euro are up as the greenback loses traction. 
Via Talk Markets
World Markets News for Tuesday
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon. 
Via Talk Markets
Research Finds COVID Pandemic Worsened Health Equity Gap
From Teva Pharmaceutical Industries Limited
Via Business Wire
Drug Troubles
The drug sector has both good news and bad. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
Upgrades 
Via Benzinga
The Best REITs To Buy Right Now Will Pay 8.5% Yield
Stocks had a great 2021, if a tad wild - the S&P 500 finished up nearly 27% for the year. But the performance of real estate investment trusts (REITs) last year flat-out blew stocks out of the water -... 
Via Talk Markets
7 Stocks to Buy That Are Nowhere Near Being Overvalued
These stocks to buy are above their lows and appear overvalued. They have more upside as growth drivers emerge lifting their prospects. 
Via InvestorPlace
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanRafael.com & California Media Partners, LLC. All rights reserved.